This protocol is judged by an institutional critique board, an independent team that opinions any medical trials involving humans. If a analyze includes a Schedule I drug, when the board approves the protocol as moral, the researchers have to make an application for an investigational new drug (IND) amount with the FDA.Using the doses packaged and